Introduction {#sec1}
============

Obesity has become a major health, social, and economic burden worldwide ([@ref37]). This is particularly concerning among children, since the prevalence of obesity and overweightness in this age group has risen by nearly 10% in the last 4 decades ([@ref61]). Indeed, the risk of carrying excess weight into adulthood and of developing morbid obesity is much greater among obese children and adolescents ([@ref68]). Overweight children are also more at risk of developing obesity related diseases like type 2 diabetes and the metabolic syndrome in later stages of life ([@ref10]).

A sedentary lifestyle and poor diet quality are known as two main contributors to obesity, as calorie-rich diets promote a positive energy balance leading to weight gain. Obesity increases the risk of developing a large number of metabolic disorders ([@ref36]). For instance, we have recently reported that only 2 weeks of high fat diet (HFD) significantly altered contractile functions of the oxidative skeletal muscle soleus in young rats, although the same result could not be observed in the glycolytic *extensor digitorum longus* (EDL) muscle ([@ref3]). Hence, long known to cause excess lipid accumulation ([@ref55]), HFDs have also been shown to stimulate the production of reactive oxygen species (ROS), thus leading to oxidative stress ([@ref7]). Strong evidence shows that sub-clinical inflammation and oxidative stress are two of the main contributors for the pathogenesis of metabolic dysfunctions in the obese state ([@ref29]). It appears as though HFD-stimulated excess ROS production ([@ref72]) can precede observable weight gain and insulin resistance ([@ref47]), indicating that oxidative stress might be a result of the diet itself and not a consequence of excess lipid accumulation. Further, HFD induces inflammation and oxidative stress in the skeletal muscle of rodents ([@ref80]; [@ref31]). Beyond its role in locomotion and posture maintenance, skeletal muscle is a key player in the regulation of metabolic homeostasis ([@ref28]). In fact, skeletal muscle insulin resistance is considered as the primary cause of type 2 diabetes ([@ref18]). Skeletal muscle dysfunctions can be induced by oxidative stress in type 2 diabetes patients ([@ref69]; [@ref21]; [@ref73]), highlighting its role in the pathogenesis of the disease ([@ref30]). Further, 6 weeks of HFD has been shown to decrease reduced glutathione (GSH) levels, an important antioxidant, in the gastrocnemius of 8-week-old Sprague--Dawley rats ([@ref1]). After a similar exposure to HFD, higher glutathione disulfide (GSSG) levels and a lower GSH:GSSG ratio were also observed in the gastrocnemius muscle of 18-week old rats ([@ref26]). However, the early mechanisms underlying such alterations remain to be elucidated. Further, it was previously shown that glutathione levels are more prone to undergo HFD-induced alterations in oxidative muscle ([@ref59]). Therefore, this study aimed to investigate the effects of a short-term (14 days) HFD on glutathione metabolism in the soleus muscle of young rats. To do so, we measured glutathione levels as well as gene expression of known factors regulating glutathione metabolism, oxidative stress, and inflammation. Thus, we hypothesized that a short-term exposure to an obesogenic diet alters glutathione production and redox potential while inducing oxidative stress and inflammation in the soleus muscle.

Materials and Methods {#sec2}
=====================

Animal Procedures {#sec3}
-----------------

This study was carried out in strict accordance with recommendations of the National Institutes of Health guide for the care and use of Laboratory animals. Before undergoing the experimental work, the protocol was approved by the *Comité Institutionnel de Protection des Animaux* (CIPA) of UQAM (Permit Number: 0515-R3--759-0516). After a 3-day acclimatization period at UQAM's animal facility, young (100--125 g; approximately 4 weeks old) male Wistar rats (Charles River, St-Constant, QC, Canada) were randomly fed with a regular chow diet (RCD; *n* = 13) or HFD (*n* = 12) for 14 days and submitted to a 12-h light/dark cycle starting at 06:00. Animals were given *ad libitum* access to the diets and water throughout the experimental protocol. Sacrifice was achieved under anesthesia (3% isoflurane at 0.5 L/min of O~2~) after a 4 h fast to standardize the feeding status of each animal. The soleus (SOL) muscle of both legs was collected for glutathione determination and RNA extraction.

Diets {#sec4}
-----

Physiological fuel values were calculated from modified Atwater factors (3.5 kcal/g carbohydrate; 3.5 kcal/g protein; 8.5 kcal/g fat). The high fat diet was prepared from purified food-grade reagents according to a commercial formulation (D12492 diet, Research Diets Inc., New Brunswick, NJ, USA). It had a macronutrient weight content of 26.3% carbohydrate (19.2% kcal), 26.2% protein (19% kcal), and 34.9% fat (61.8% kcal) and a physiological fuel value of 4.80 kcal/g. Carbohydrate sources were maltodextrin and sucrose (64.5 and 35.5%, respectively), protein sources were casein and L-cystine (98.5 and 1.5%, respectively), while lipid sources were lard and soybean oil (90.7 and 9.3%, respectively). The diet also contained cellulose (64.6 g/kg), calcium carbonate (7.1 g/kg), dicalcium phosphate (16.8 g/kg), potassium citrate (21.3 g/kg), and choline bitartrate (2.6 g/kg), as well as mineral (12.9 g/kg) and vitamin (12.9 g/kg) mixes. The regular chow diet (Charles River Rodent Diet \# 5075, Cargill Animal Nutrition, MN, USA) had a macronutrient weight content of 55.2% carbohydrate (65.6% kcal), 18% protein (21.4% kcal), and 4.5% fat (13% kcal) and a physiological fuel value of 2.89 kcal/g.

Glutathione Measurements {#sec5}
------------------------

Immediately after collection, 0.25 g of SOL muscle was homogenized (2 × 10 s with Polytron Teador; Biospec Products Inc, Dremel-Racine, WI) in 1.25 ml of iced and freshly prepared 5% (w/v) metaphosphoric acid (Fisher A280--100) and centrifuged for 3 min at 7200 *g*. Pellets and supernatants were kept at −80°C until protein and glutathione determinations, respectively. Reduced glutathione (GSH) and glutathione disulfide (GSSG) were quantified by capillary (75-μm × 50-cm silica) electrophoresis (75 mM boric acid and 25 mM Bis-Tris, pH 8.4, 28°C, 18 kV) as described previously ([@ref40]). The redox potential was defined as the half-cell reduction potential of the GSSG (2H^+^/2GSH couple) and calculated by using the Nernst equation (25°C, pH 7.0) ([@ref70]).

RNA Extraction {#sec6}
--------------

Collected tissue samples were stored in RNAlater stabilization solution (Ambion) and stored at −20°C for later use. About 15 to 60 mg of tissue per sample was homogenized in 1 ml of TRIzol Reagent (Ambion) with a TissueLyserII homogenizer (Qiagen) and extracted according to the manufacturer's instructions. Samples were further processed using the PureLink RNA Mini Kit (Ambion), and contaminating DNA was removed *via* DNase on-column digestion. A BioDrop spectrophotometer was used to determine RNA concentrations, and the ratio of absorbance at 260 and 280 nm is used to assess purity. RNA integrity was evaluated by visualization of intact 18S and 28S RNA bands following agarose gel electrophoresis. SuperScript VILO Master Mix (Invitrogen) was used to synthesize cDNA with 1 μg of RNA per 20 μl reaction.

RNA Sequencing {#sec7}
--------------

RNA sequencing methodology was adapted from [@ref54]. Briefly, libraries were prepared using the Illumina TruSeq protocol. Once prepared, indexed cDNA libraries were pooled (six libraries per pool) in equimolar amounts, and the majority was sequenced with single-end 101 bp reads on the Illumina HiSeq4000. Low quality score bases and adaptor sequences were first trimmed using Trim Galore (version 0.2.7). The resulting reads were then mapped to a genome reference sequence (Ensembl Rnor_6.0 release 81) with STAR (version 2.4.2) using the 1-pass protocol. The number of mismatches allowed for the pairs was of 5, and a soft-clipping step that optimizes alignment scores was automatically applied by the STAR software. Read counting on each gene was done with HTseq (version 0.6.1p1), which was launched separately on each alignment file with the intersection-nonempty option, supported by SAMtools (version 0.1.19) using the same gene reference file as for the alignments.

Statistical Analyses {#sec8}
--------------------

Sample sizes were calculated as recommended ([@ref15]) using data from previously published studies, as well as our own pilot studies using power set at 0.8 (80%) and significance set at *p* \< 0.05. All values are presented as means ± SD, except where noted. Normality was assessed using the Shapiro--Wilk test. Unpaired Student's *t* tests were used to compare values between the two groups. Statistical analyses were performed using the SPSS 16.0 (IBM Corporation, Armonk, NY) software. For RNA-Seq analyses, the DESeq2 (version 1.18.1) software was used to identify genes with a significantly different expression in the HF group. A FDR-adjusted *p* \< 0.10, corresponding to the treatment variable, and an absolute fold change of mean expression level greater than 1.5 was required to qualify a gene as significantly differently expressed ([@ref44]). Significance for all other statistical analyses was set at *p* \< 0.05.

Results {#sec9}
=======

As previously reported ([@ref2],[@ref3]), we found no significant difference in body weight between both groups (data not shown). We observed significantly lower total glutathione levels in the soleus muscle of the HFD group (*p* = 0.046; [Figure 1A](#fig1){ref-type="fig"}), which was largely due to the significant 25% decrease of GSH levels (*p* = 0.042; [Figure 1B](#fig1){ref-type="fig"}). However, we did not find any difference in GSSG levels (*p* = 0.722; [Figure 1C](#fig1){ref-type="fig"}), GSH:GSSG ratio (*p* = 0.693; [Figure 2A](#fig2){ref-type="fig"}), or glutathione redox potential (*p* = 0.534; [Figure 2B](#fig2){ref-type="fig"}).

![Soleus muscle levels of total glutathione **(A)**, GSH **(B)** and GSSG **(C)** in young rats submitted to 14 days of HFD or RCD. Results are presented as means ± SD for *n* = 12--13; \* indicates significant difference between the two groups (*p* \< 0.05).](fphys-10-00372-g001){#fig1}

![Soleus muscle GSH:GSSG ratio **(A)** and glutathione redox potential **(B)** in young rats submitted to 14 days of HFD or RCD. Results are presented as means ± SD for *n* = 12--13.](fphys-10-00372-g002){#fig2}

When looking at gene expression levels, we did not find any significant differences in glutathione metabolism ([@ref60]) enzymes glutamate cysteine ligase catalytic subunit (GCLC; adjusted *p* = 0.865), glutamate cysteine ligase modifier subunit (GCLM; adjusted *p* = 0.800), glutathione synthase (GSS; adjusted *p* = 0.984), methionine synthase (MTR; adjusted *p* = 0.917), glutathione reductase (GSR; adjusted *p* = 0.978), γ-glutamyltransferase-7 (GGT7; adjusted *p* = 0.248), or the Nrf2 transcription factor (NFE2L2; adjusted *p* = 0.990; [Figure 3A](#fig3){ref-type="fig"}). Further, we did not find any differences in major antioxidant enzymes glutathione peroxidase (GPX; adjusted *p* = 0.912), catalase (CAT; adjusted *p* = 0.399), or mitochondrial superoxide dismutase (SOD2; adjusted *p* = 0.600; [Figure 3B](#fig3){ref-type="fig"}).

![Relative gene expression levels of various enzymes and transcription factors implicated in the glutathione metabolism **(A)** and relative gene expression levels of major antioxidant enzymes **(B)** in the soleus muscle of young rats submitted to 14 days of HFD. Results are presented as mean fold change, compared to the RCD group, ±SEM for 5--6 replicates per condition.](fphys-10-00372-g003){#fig3}

We observed a significant 4.5 fold increase in the expression of interleukin 6 (IL6; adjusted *p* = 0.05) in the HFD group, but not of its receptor (IL6R; adjusted *p* = 0.913) or of any other interleukins or their respective receptor (adjusted *p* ≥ 0.902; [Figure 4A](#fig4){ref-type="fig"}). Expression levels were also similar for the cytokine transforming growth factor β (TGFB; adjusted *p* ≥ 0.579; [Figure 4B](#fig4){ref-type="fig"}) superfamily genes. However, we observed a significant increase in the expression of other proteins implicated in pro-inflammatory pathways, such as a 5.4 fold increase in angiopoietin-like 4 (ANGPTL4; adjusted *p* = 0.009), a 3 fold increase in cell death activator CIDE-A (CIDEA; adjusted *p* \< 0.001), a 4 fold increase in pentraxin-related protein PTX3 (PTX3; adjusted *p* = 0.006), and a 2.2 fold increase in long-chain fatty acid transport protein 1 (SLC27A1/FATP1; adjusted *p* \< 0.001; [Figure 4C](#fig4){ref-type="fig"}).

![Relative gene expression levels of various interleukins and their respective receptors **(A)**, relative gene expression levels of TGF-β cytokines **(B)** as well as relative gene expression of various pro-inflammatory proteins **(C)** in the soleus muscle of young rats submitted to 14 days of HFD. Results are presented as mean fold change, compared to the RCD group, ±SEM for 5--6 replicates per condition; \* indicates significant difference between the two groups (adjusted *p* \< 0.10).](fphys-10-00372-g004){#fig4}

Finally, we did not observe any difference in the gene expression levels of NF-κB (NFKB; adjusted *p* ≥ 0.801; [Figure 5A](#fig5){ref-type="fig"}) protein complex members or NADPH oxidase isoforms (NOX; adjusted *p* ≥ 0.801; [Figure 5B](#fig5){ref-type="fig"}) between both groups.

![Relative gene expression levels of NF-κB **(A)** and relative gene expression levels of various NADPH oxidase isoforms **(B)** in the soleus muscle of young rats submitted to 14 days of HFD. Results are presented as mean fold change, compared to the RCD group, ±SEM for 5--6 replicates per condition.](fphys-10-00372-g005){#fig5}

Discussion {#sec10}
==========

The present study intended to clarify the effects of a short-term HFD on the mechanisms regulating glutathione metabolism, the development of oxidative stress, and inflammation in the soleus (SOL) muscle of young rats. To our knowledge, the present results are first to demonstrate reduced glutathione levels after such a short exposure to HFD. After measuring the expression levels of a host of enzymes involved in the regulation of glutathione metabolism, results suggest that this decrease in GSH is not due to an alteration in *de novo* synthesis or GSSG recycling *via* GSR. Further, a significant increase in the expression of the pro-inflammatory cytokine interleukin 6 (IL-6) in the SOL muscle suggests an involvement in early metabolic alterations that can disrupt lipid and glucose metabolisms. These alterations precede any observable weight gain but could contribute to the mechanisms of impaired insulin signaling ([@ref47]), which could ultimately lead to the development of type 2 diabetes ([@ref74]), as well as other metabolic disorders ([@ref46]).

Multiple studies have previously reported HFD-induced altered GSH or GSSG levels or ratio in rodent skeletal muscle ([@ref1]; [@ref62]; [@ref25]; [@ref81]; [@ref31]; [@ref59]). However, the expression of both GCL subunits (the rate-limiting enzymes in the *de novo* synthesis of GSH), or of GSR (catalyzing the reduction of GSSG into GSH), was not altered, as previously reported in mice liver ([@ref83]). The latter study hypothesized that HFD could alter GSH levels *via* glutathione synthesis-related gene promoters hypermethylation. In the same study, a diet supplemented with serine, a cysteine precursor, was shown to counteract the alterations in GSH production and the development of oxidative stress induced by a HFD in hepatic tissues. This is of great interest, since cysteine availability is the rate-limiting factor of cellular GSH synthesis ([@ref45]). As shown in previous work ([@ref2]), our HFD formulation is supplemented with L-cystine, the oxidized dimer form of cysteine. Therefore, we conclude that reduced glutathione levels observed in this study were not a consequence of decreased cysteine availability caused by a lack of nutritional intake, as L-cystine supplementation was previously shown to stimulate GSH production ([@ref79]). In that same study, using the same diet and protocol, we observed significantly lighter livers in HFD rats ([@ref2]). Glutathione levels are at their highest in liver (where it is primarily synthesized), which also plays an important role in glutathione inter-organ homeostasis ([@ref53]). However, it appears that hepatic GSH needs to reach extreme depletion before it can affect skeletal muscle GSH concentrations ([@ref14]). Further, the hepatic cysteine concentration is not considered to be a limiting step of GSH synthesis, as methionine is converted to cysteine. Nevertheless, the first enzyme in this metabolic cascade, methionine adenosyltransferase, can be inhibited by oxidative molecules ([@ref24], [@ref23]). On the other hand, a more recent study hypothesized that skeletal muscle glutamine levels could influence hepatic GSH production in the presence of oxidative stress ([@ref9]). Thus, HFD-modulated interactions between liver and skeletal muscle glutathione metabolism need to be clarified.

As GSH reduces hydrogen peroxide (H~2~O~2~) through GPX, the levels of GSSG, a product of that reaction, rise. Under cellular stress, GSH levels drop as GSSG accumulates in the cell, although it can also react with the free sulfhydryl group of a protein to form a mixed disulfide or be transported out of the cell ([@ref45]). Hence, the GSH:GSSG ratio is a good indicator of cellular oxidative stress ([@ref63]). We did not observe any significant HFD-induced changes in GSSG levels or in the GSH:GSSG ratio. This, combined with the lack of difference in the expression of major antioxidant enzymes GPX, CAT, and MnSOD or in various isoforms of NADPH oxidase, a superoxide precursor, would suggest that the soleus muscle is not under cellular stress, yet. This would confirm earlier findings from our group that showed no increase in ROS (H~2~O~2~) production from permeabilized soleus muscle fibers in rats submitted to the same 14-day HFD ([@ref41]). Nonetheless, *in vivo* measurements of H~2~O~2~ and malondialdehyde (MDA), a product of lipid peroxidation and widely used marker of oxidative stress ([@ref50]), could provide further confirmation of these observations. The present results do not show any difference in the glutathione redox potential as calculated by the Nernst equation. However, this equation's validity as an indicator of cellular redox potential is currently debated in the literature, as it appears that the redox potential is highly dependent of GSH but not GSSG levels ([@ref27]). Moreover, further evidence points toward the redox potential, depending predominantly on kinetics *per se* rather than thermodynamic constraints ([@ref20]). A major consequence of the observed 25% drop in GSH levels is a decreased capacity to detoxify endogenous peroxides *via* GPX. Thus, it is appealing to postulate that, under exercise-induced physical stress and accelerated ROS production ([@ref67]), the SOL antioxidant defense system will be compromised in HFD rats due to significantly lower GSH levels. Measurements of skeletal muscle glutathione levels following an exercise bout could confirm this hypothesis.

The other major finding of this study is the 4.5 fold increase in the gene expression of pro-inflammatory cytokine IL-6, which has previously been shown to be increased in the obese state ([@ref22]) and diminished after weight loss ([@ref12]). Further, elevated IL-6 levels are a good indicator of an inflamed state, which can play a key role in the development of insulin resistance and other associated diseases ([@ref78]). Its production can be regulated by various factors like C/EBPβ ([@ref38]) and PPARγ-activated proteins ANGPTL4 ([@ref58]), CIDEA ([@ref16]), and FATP1 ([@ref51]). Interestingly, PPARγ has often been associated to Il-6 inhibition through STAT3 inactivation ([@ref75]). However, other evidence suggests that PPARγ could trigger IL-6 production in skeletal muscle ([@ref5]) and other cell types and tissues ([@ref76]; [@ref82]). Here, our data suggest that PPARγ, whose activity has been shown to be modulated by lipid ingestion ([@ref19]), could stimulate IL-6 expression through the activation of other proteins. In turn, IL-6 can induce the production of other pro-inflammatory proteins like PTX3 ([Figure 6](#fig6){ref-type="fig"}; [@ref6]). Co-incidence of elevated IL-6 and lower GSH levels was previously reported ([@ref71]), while obesogenic diets were shown to induce both of these effects in mice ([@ref35]) and rats ([@ref32]). In individuals with type 2 diabetes, increased IL-6 levels have been suspected as a cause of lowered GSH levels ([@ref39]). In mice, IL-6 was associated with glutathione depletion in the skeletal muscle, a mechanism possibly involving increased cysteine catabolism ([@ref33]). Further, IL-6 has been shown to promote GSH release, but not production, from the liver into blood ([@ref52]). It remains to be seen if such a phenomenon could occur in the skeletal muscle. Furthermore, GSH has been shown to inhibit IL-6 production in patients with liver cirrhosis ([@ref56]). Induced GSH depletion has also been demonstrated to inhibit T helper cell T~h~1 response in favor of T~h~2 response, which is responsible for IL-6 production ([@ref57]; [@ref13]). Thus, elevated IL-6 expression could also be consequential to low GSH levels. On the other hand, we did not observe a different expression of the IL-33 gene in the HFD group, which stimulates the production of T~h~2-associated cytokines ([@ref64]). In both groups, we also found similar gene expression of other pro-inflammatory cytokines of the interleukin-1 superfamily, including IL-1β, whose expression has been shown to be stimulated by HFD in the *vastus lateralis* muscle of rats ([@ref17]). In light of those results, it seems appropriate to recommend that the underlying mechanisms of glutathione and interleukin interactions should be further investigated in future studies.

![Suggested interplay between HFD, GSH levels and IL-6 expression in rat soleus muscle. The high-fat diet promptly promotes the expression of IL-6. This is stimulated by an increase in C/EBPβ ([@ref38]) and PPARγ activity ([@ref19]), the latter which yields the upregulation of pro-inflammatory proteins ANGPTL4, CIDEA and FATP1. In turn, IL-6 increases the expression of PTX3 and promotes cysteine catabolism ([@ref33]), which lowers GSH levels. The latter are also decreased *via* HFD through a mechanism that was previously proposed to involve glutathione synthesis-related gene promoters hypermethylation ([@ref83]). Ultimately, the present results show that HFD promptly alters the antioxidant defense system while promoting inflammation and disruption in skeletal muscle homeostasis.](fphys-10-00372-g006){#fig6}

In order to better assess the inflammatory status of the SOL muscle, the expression of TGF-β cytokine superfamily isoforms was also considered, as it was reported to decrease GSH levels in multiple cell types, *in vitro* ([@ref43]), possibly *via* the suppression of GCLC expression ([@ref4]). Further, HFD was shown to induce a rise in TGF-β levels in both rats and mice ([@ref77]; [@ref66]). We could not, however, observe similar results after submitting young rats to a 2-week HFD. Therefore, we cannot postulate that TGF-β influences glutathione metabolism at this early stage. As discussed above, a decrease in the GSH concentration, as a glutathione peroxidase substrate, will result in a lower detoxification of endogenous peroxide, allowing an increase in the intracellular concentration of H~2~O~2~. Because it activates NF-κB, H~2~O~2~ could therefore stimulate the increase of IL-6. Indeed, NF-κB is a major mediator of the inflammation cascade and its activation can be either stimulated or inhibited by GHS, depending on the tissue of interest and the experimental model ([@ref34]). Increased NF-κB phosphorylation was also observed in the gastrocnemius muscle of rats after 16 weeks of HFD ([@ref65]). Chronic NF-κB activation may be involved in the development of several diseases, including obesity and type 2 diabetes ([@ref42]). We could not, however, detect any difference in the expression of NF-κB between HFD and RCD rats after 2 weeks, underlining that, in our model, HFD could impact endogenous metabolism rather than gene expression.

Results presented in this study demonstrate that a short-term high fat diet induces lower GSH levels in the SOL muscle of young rats. This effect can neither be attributed to a decrease in the expression of glutathione synthesis-implicated enzymes nor to observable oxidative stress. However, decreased GSH levels suggest a potentially altered antioxidant defense system. Moreover, 2 weeks of HFD induced a significant increase in IL-6 gene expression, which suggests its interaction with skeletal muscle glutathione metabolism. It was previously reported that IL-6 mRNA expression is increased in response to contractions or to glycogen depletion in the skeletal muscle ([@ref48]). The present data, coinciding with our previous results, raise the hypothesis that disruptions in the antioxidant defense system, coupled to inflammation activation, could play a role in the impairment of contractile functions in the soleus muscle of young rats submitted to only 14 days of HFD. It was previously shown that IL-6 plays a pivotal role in muscle wasting mechanisms ([@ref8]), although we could not observe evidence of atrophy in neither SOL nor EDL in our previous results ([@ref3]). On the other hand, GSH has been shown to improve Ca^2+^ sensitivity in rat skeletal muscle, although this was only observed in fast twitch fibers ([@ref49]) in which fast skeletal muscle troponin isoforms are highly expressed. Further, it appears as though diets rich in saturated fatty acids could alter fast skeletal muscle troponin T (TNNT3 gene) expression through alternative splicing of pre-mRNA in rat skeletal muscle ([@ref11]), although it remains to be seen if HFD could also alter the expression of other proteins of the troponin complex (troponin C and troponin I). Thus, further studies are needed to elucidate what role glutathione and inflammation could play in impaired oxidative muscle contractile functions and to better clarify the mechanisms (including the role of the liver and IL-6) underlying the reduction of GSH levels observed in the SOL muscle of young rats submitted to a short-term HFD.
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